Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Erosive Esophagitis (EE)”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Large-scale testing (Phase 3)Study completedNCT01452776
What this trial is testing

Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive Esophagitis

Who this might be right for
Erosive Esophagitis
Takeda 305
Not applicableStudy completedNCT01867931
What this trial is testing

Epithelial Damage in GERD

Who this might be right for
Gastro-esophageal Reflux Disease
Maastricht University Medical Center 34
Large-scale testing (Phase 3)Study completedNCT01459367
What this trial is testing

Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive Esophagitis

Who this might be right for
Erosive Esophagitis
Takeda 607
Large-scale testing (Phase 3)Study completedNCT03615677
What this trial is testing

Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis

Who this might be right for
Erosive Esophagitis (EE)
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. 261
Testing effectiveness (Phase 2)UnknownNCT01129713
What this trial is testing

Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.

Who this might be right for
Gastroesophageal Reflux Disease (GERD)HeartburnIndigestion
Effexus Pharmaceutical 40
Testing effectiveness (Phase 2)Ended earlyNCT02615184
What this trial is testing

Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

Who this might be right for
Erosive Esophagitis
Takeda 24
Early research (Phase 1)Study completedNCT07278349
What this trial is testing

Bioequivalence Study to Compare Vonoprazan 20 mg Film Coated Tablets Versus Voquezna® 20 mg (Vonoprazan) Tablets

Who this might be right for
Erosive GastritisErosive Esophagitis(EE)HELICOBACTER PYLORI INFECTIONS
Humanis Saglık Anonim Sirketi 28
Early research (Phase 1)Study completedNCT02141711
What this trial is testing

TAK-438 - Safety, Blood Levels & Effects of Repeated Doses

Who this might be right for
Erosive Esophagitis(EE)Gastroesophageal Reflux Disease (GERD)
Takeda 48
Post-approval studies (Phase 4)Study completedNCT02679508
What this trial is testing

Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety

Who this might be right for
Erosive Esophagitis
Takeda 208
Post-approval studies (Phase 4)Study completedNCT00242736
What this trial is testing

An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)

Who this might be right for
GERD
AstraZeneca 350
Large-scale testing (Phase 3)Active Not RecruitingNCT07037875
What this trial is testing

A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)

Who this might be right for
GERD (Gastroesophageal Reflux Disease)
Cinclus Pharma Holding AB 500
Large-scale testing (Phase 3)WithdrawnNCT07313774
What this trial is testing

A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Maintenance of Healing in Participants With Healed Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)

Who this might be right for
GERD (Gastroesophageal Reflux Disease)
Cinclus Pharma Holding AB
Post-approval studies (Phase 4)Study completedNCT00644735
What this trial is testing

Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed

Who this might be right for
Erosive Esophagitis
AstraZeneca 750